Novo Nordisk CEO steps down amid market challenges, including competition from Eli Lilly's rival drug and setbacks with Novo Nordisk's obesity treatments.
Former FBI Director James Comey's Instagram post sparks investigation by DHS and Secret Service over alleged assassination threat against President Trump.
Novo Nordisk CEO steps down amid market challenges, including competition from Eli Lilly's rival drug and setbacks with Novo Nordisk's obesity treatments.
Former FBI Director James Comey's Instagram post sparks investigation by DHS and Secret Service over alleged assassination threat against President Trump.